Patents by Inventor Jessica Teh

Jessica Teh has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • E2F reporter melanoma cells
    Patent number: 11571483
    Abstract: A modified melanoma cell line capable of quantification of the effects of MEK inhibitors and CDK4/6 inhibitors in a quantitative, temporal and non-invasive manner both in vitro and in vivo.
    Type: Grant
    Filed: September 3, 2020
    Date of Patent: February 7, 2023
    Assignee: THOMAS JEFFERSON UNIVERSITY
    Inventors: Andrew Aplin, Jessica Teh
  • E2F REPORTER MELANOMA CELLS
    Publication number: 20210194941
    Abstract: A modified melanoma cell line capable of quantification of the effects of MEK inhibitors and CDK4/6 inhibitors in a quantitative, temporal and non-invasive manner both in vitro and in vivo.
    Type: Application
    Filed: September 3, 2020
    Publication date: June 24, 2021
    Applicant: THOMAS JEFFERSON UNIVERSITY
    Inventors: Andrew Aplin, Jessica Teh
  • E2F REPORTER MELANOMA CELLS
    Publication number: 20180180594
    Abstract: A modified melanoma cell line capable of quantification of the effects of MEK inhibitors and CDK4/6 inhibitors in a quantitative, temporal and non-invasive manner both in vitro and in vivo.
    Type: Application
    Filed: December 21, 2017
    Publication date: June 28, 2018
    Applicant: THOMAS JEFFERSON UNIVERSITY
    Inventors: Andrew Aplin, Jessica Teh
  • E2F reporter melanoma cells
    Patent number: 9880150
    Abstract: A method of using a modified melanoma cell capable of quantification of the effects of MEK inhibitors and CDK4/6 inhibitors in a quantitative, temporal and non-invasive manner both in vitro and in vivo.
    Type: Grant
    Filed: January 28, 2016
    Date of Patent: January 30, 2018
    Assignee: THOMAS JEFFERSON UNIVERSITY
    Inventors: Andrew Aplin, Jessica Teh
  • E2F REPORTER MELANOMA CELLS
    Publication number: 20160216251
    Abstract: A modified melanoma cell line capable of quantification of the effects of MEK inhibitors and CDK4/6 inhibitors in a quantitative, temporal and non-invasive manner both in vitro and in vivo.
    Type: Application
    Filed: January 28, 2016
    Publication date: July 28, 2016
    Inventors: Andrew Aplin, Jessica Teh